Hotgen

China
Shuanghejiedao, Sichuan, China
400-815-1117 ★

Company profile

Hotgen company profile

Hotgen engages in research, develops, and manufactures medical and public safety inspection products. It is a diagnostic technology platform that develops and expands liquid biopsy early screening technology for cancer and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation. Their technology deploys antibody drugs, live bacteria drugs, exosome drugs, and other biopharmaceutical fields and creates a development strategy for the entire industry chain, from diagnosis to treatment.

Business identity

Contact email
[email protected]
Phone number
400-815-1117
Operating status
Active
Company type
For Profit
Employee range
01001-05000 employees
Founded
2005-06-23

Headquarters

Headquarters
Shuanghejiedao, Sichuan, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
3
Total equity funding
$5M
Last funding
Series B / $3M / 2019-01-11
Last equity funding
Series B / $3M
Investors
3
Lead investors
2
Exited on
2019-09-30

Founders and investors

Lead investors

Fortune Venture CapitalShenZhen GTJA Investment Group

Investors

Fortune Venture CapitalGreenriver InvestmentShenZhen GTJA Investment Group

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.